Comparing efficiency of insulin glargine vs. NPH insulin in patients with type 2 diabetes

被引：0
|
作者：
Kodela, B. [1 ]
Petrovic, J. [2 ]
Velickovic-Radovanovic, R. [2 ]
Lilic, R. [2 ]
Radenkovic, S. [2 ]
Dedovic, I [3 ]
机构：
[1] Pharmaceut Inst, Nish, Serbia
[2] Ctr Clin, Nish, Serbia
[3] Fac Farm, Nish, Serbia
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)64951-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A254 / A254
页数：1
相关论文
共 50 条
  • [31] Comparison of insulin Glargine (HOE901) vs NPH insulin during 1 year of insulin combination therapy in type 2 diabetes
    Yki-Jarvinen, H
    Dressler, A
    Zieman, M
    [J]. DIABETES, 2000, 49 : A130 - A131
  • [32] Cardiovascular Events in Type-2-Diabetes: Insulin Degludec vs. Glargine
    Lichert, Frank
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (22) : 1642 - +
  • [33] Diabetic retinopathy in patients with type 1 diabetes treated with insulin glargine or NPH
    Peters, K
    Garg, SK
    JAckson, WE
    Mackenzie, T
    Queen, J
    Anil, S
    Chase, HP
    [J]. DIABETES, 2001, 50 : A443 - A443
  • [34] Concomitant use of insulin glargine and NPH in type I diabetes
    Khadilkar, VV
    Khadilkar, AV
    [J]. INDIAN PEDIATRICS, 2005, 42 (08) : 796 - 800
  • [35] Fasting blood glucose for insulin adjustment with insulin glargine or NPH insulin combined with sulphonylurea in Type 2 diabetes
    Haupt, A
    Eckert, H
    Schweitzer, MA
    Peiker, J
    Häring, HU
    Fritsche, A
    [J]. DIABETOLOGIA, 2004, 47 : A269 - A269
  • [36] A Randomized Controlled Trial Comparing Liraglutide vs. Glargine Insulin for the Management of Patients with Type 2 Diabetes after Hospital Discharge
    Pasquel, Francisco J.
    Urrutia, Maria A.
    Cardona, Saumeth
    Iacobellis, Gianluca
    Farias, Javier, Sr.
    Chaudhuri, Ajay
    Anzola, Isabel
    Palacios, Juan D.
    Albury, Bonnie S.
    Gomez, Patricia C.
    Zamudio, Karla W.
    Perez-Guzman, Mireya C.
    Vellanki, Priyathama
    Fayfman, Maya
    Haw, Jeehea Sonya
    Galindo, Rodolfo J.
    Davis, Georgia
    Migdal, Alexandra
    Peng, Limin
    Umpierrez, Guillermo E.
    [J]. DIABETES, 2020, 69
  • [37] Economic analysis of insulin glargine compared with NPH insulin in the treatment of patients with Type 1 diabetes in Spain
    Terrés, CR
    Rodríguez, J
    Bolinder, B
    de Pablos, P
    [J]. DIABETOLOGIA, 2004, 47 : A345 - A345
  • [38] Outcomes with insulin glargine in patients with type 2 diabetes previously on NPH insulin: evidence from clinical practice in Spain
    Delgado, E.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2012, 66 (03) : 281 - 288
  • [39] Cost advantages and improved patient treatment satisfaction with insulin glargine in type 2 diabetes patients.: The long-acting insulin glargine vs. NPH insulin cost evaluation study in Germany (LIVE-DE)
    Scholten, T.
    Kohlmann, T.
    Moock, J.
    Holle, R.
    Landgraf, W.
    Pirk, O.
    Hauner, H.
    [J]. DIABETOLOGIA, 2008, 51 : S405 - S405
  • [40] Nocturnal glucose metabolism after a single bedtime injection of insulin glargine or NPH insulin in patients with type 2 diabetes
    Fischer, Britta
    Soydan, Nedim
    Eckhard, Michael
    Ehl, Julia
    Kunz, Clemenis
    Bretzel, Reinhard G.
    Linn, Thomas
    [J]. DIABETES, 2006, 55 : A111 - A111
12345